Beneficial role of tolvaptan in the control of body fluids without reductions in residual renal function in patients undergoing peritoneal dialysis

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis

Volumn 29, Issue , 2013, Pages 33-37

  Mori, Takefumi ^a   Oba, Ikuko ^a   Koizumi, Kenji ^a   Kodama, Mayumi ^a   Shimanuki, Miwako ^a   Tanno, Mizuho ^a   Chida, Makiko ^a   Saito, Mai ^a   Kiyomoto, Hideyasu ^a   Miyazaki, Mariko ^a   Ogawa, Susumu ^a   Sato, Hiroshi ^a   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAZEPINE DERIVATIVE; DIURETIC AGENT; TOLVAPTAN; VASOPRESSIN RECEPTOR ANTAGONIST;

ADULT; AGED; BODY FLUID; DRUG EFFECTS; FEMALE; HEART FAILURE; HUMAN; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; METABOLISM; MIDDLE AGED; OSMOLARITY; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; URINE;

ADULT; AGED; ANTIDIURETIC HORMONE RECEPTOR ANTAGONISTS; BENZAZEPINES; BODY FLUIDS; DIURETICS; FEMALE; HEART FAILURE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PERITONEAL DIALYSIS; URINE;

EID: 84893172523     PISSN: 11978554     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)